Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol fumarate inhalation solution for COPD in adults
CTR20200496Phase 3Completed
- Sponsor
- Joincare Pharmaceutical
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Joincare Pharmaceutical. Started May 2020; status: completed.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20200496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200496.